UCB Korea, Samil to strengthen co-marketing over Xyzal

UCB Korea and Samil Pharm will beef up their co-marketing efforts of XYZAL (levocetirizine), a third-generation non-sedative antihistamine.

Many people suffer from the symptoms associated with common allergic conditions. The immune system of allergy sufferers over-reacts to something in the environment, leading to symptoms that affect their respiratory system, eyes, or skin.

The two compa...